We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$789M
AUM Growth
-$30.8M
Cap. Flow
-$19.4M
Cap. Flow %
-2.46%
Top 10 Hldgs %
49.57%
Holding
138
New
14
Increased
15
Reduced
36
Closed
14

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$7.4M
2
AAPL icon
Apple
AAPL
+$2.4M
3
ABT icon
Abbott
ABT
+$552K
4
SNY icon
Sanofi
SNY
+$536K
5
NKE icon
Nike
NKE
+$529K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.06M
2
SLB icon
SLB Ltd
SLB
+$5.21M
3
MO icon
Altria Group
MO
+$4.49M
4
PM icon
Philip Morris
PM
+$4.4M
5
MDLZ icon
Mondelez International
MDLZ
+$2.49M

Sector Composition

Rank Sector Weight
1 Financials 26.52%
2 Healthcare 21.36%
3 Industrials 14.67%
4 Technology 13.3%
5 Communication Services 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEG icon
126
Aegon
AEG
$13.5B
-134,504
Closed -$532K
AMG icon
127
Affiliated Managers Group
AMG
$9.46B
-2,492
Closed -$405K
CM icon
128
Canadian Imperial Bank of Commerce
CM
$107B
-7,018
Closed -$262K
GSK icon
129
GSK
GSK
$103B
-11,752
Closed -$596K
IP icon
130
International Paper
IP
$22.3B
-14,921
Closed -$580K
KHC icon
131
Kraft Heinz
KHC
$30.4B
-19,838
Closed -$1.56M
L icon
132
Loews
L
$24.3B
-22,205
Closed -$850K
MCD icon
133
McDonald's
MCD
$188B
-1,615
Closed -$203K
RY icon
134
Royal Bank of Canada
RY
$291B
-4,597
Closed -$265K
TD icon
135
Toronto Dominion Bank
TD
$198B
-6,389
Closed -$276K
TIP icon
136
iShares TIPS Bond ETF
TIP
$14.5B
-1,860
Closed -$213K
ENDP
137
DELISTED
Endo International plc
ENDP
-9,230
Closed -$260K
BBEP
138
DELISTED
BREITBURN ENERGY PARTNERS LP COM UNITS RPTNG LTD PRTNRSHIP
BBEP
-10,500
Closed -$6K

Similar funds

Cannell & Spears's Q2 2016 Portfolio in Review

As of Q2 2016, Cannell & Spears held 138 positions worth $789M, down 3.8% from $819M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cannell & Spears's Q2 2016 filing shows 14 new, 15 increased, 36 reduced and 14 closed positions. Its largest new stake was Abbott: 13,873 shares worth $545K. The largest sale was Thermo Fisher Scientific, an estimated $6.06M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Cannell & Spears's largest Q2 2016 buy was Abbott: 13,873 shares worth $545K.
  • Cannell & Spears added most to Allergan plc in Q2 2016, an estimated $7.4M increase.
  • Cannell & Spears's biggest Q2 2016 reduction was Thermo Fisher Scientific, cutting an estimated $6.06M.
  • Cannell & Spears fully exited Kraft Heinz in Q2 2016, selling an estimated $1.56M.
  • Cannell & Spears's ten largest holdings make up 50% of its $789M portfolio in Q2 2016.
  • Cannell & Spears opened 14 new positions and closed 14 in Q2 2016.
  • Cannell & Spears's portfolio value fell 3.8% quarter-over-quarter to $789M.

Based on Cannell & Spears's 13F filing for Q2 2016, filed 10 Aug 2016.